XML 42 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Equity (Tables)
9 Months Ended
Oct. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule Of Shares Reserved For Future Issuance
The Company had reserved shares of common stock for future issuance as follows:
October 31, 2020January 31, 2020
Redeemable convertible preferred stock— 169,921,272 
Common stock warrants— 32,336 
2012 Equity Incentive Plan:
Options outstanding69,634,367 80,903,200 
RSUs outstanding7,616,097 — 
Shares available for future grants— 412,401 
2020 Equity Incentive Plan:
Shares available for future grants34,342,175 — 
2020 ESPP Plan:5,700,000 — 
Total shares of common stock reserved for future issuance117,292,639 251,269,209 
Option Activity Rollforward
Stock option activity and activity regarding shares available for grant under the 2012 Plan and the 2020 Plan during the nine months ended October 31, 2020 is as follows:
Shares
Available for Grant
Number of Options OutstandingWeighted-
Average
Exercise Price
Weighted-Average Remaining Contractual Life
(in years)
Aggregate
Intrinsic
Value
(in thousands)
Balance—January 31, 2020
412,401 80,903,200 $6.21 8.6$1,546,313 
Shares authorized20,870,187 — 
Options granted(610,936)610,936 $26.64 
Options exercised — (4,945,720)$2.23 
Options forfeited1,354,238 (1,354,238)$5.47 
Repurchase of unvested common stock40,000 — 
RSUs granted(2,295,492)— 
RSUs forfeited10,000 — 
Balance—April 30, 2020
19,780,398 75,214,178 $6.65 8.5$2,416,057 
Options granted(130,025)130,025 $34.49 
Options exercised— (1,898,922)$5.19 
Options forfeited1,216,461 (1,216,461)$8.68 
RSUs granted(2,587,289)— 
RSUs forfeited19,550 — 
Balance—July 31, 2020
18,299,095 72,228,820 $6.70 8.2$6,227,842 
Shares authorized34,100,000
Shares ceased to be available for issuance under the 2012 Plan(15,696,031)
Options granted(136,000)136,000$71.91 
Options exercised(2,186,819)$4.74 
Options forfeited543,634(543,634)$7.52 
RSUs granted(2,841,823)
RSUs forfeited73,300
Balance—October 31, 2020
34,342,17569,634,367$6.88 8.0$16,930,996 
Vested and exercisable as of October 31, 2020
26,842,544$4.86 7.4$6,580,709 
Option Rollforward Schedule
Stock option activity and activity regarding shares available for grant under the 2012 Plan and the 2020 Plan during the nine months ended October 31, 2020 is as follows:
Shares
Available for Grant
Number of Options OutstandingWeighted-
Average
Exercise Price
Weighted-Average Remaining Contractual Life
(in years)
Aggregate
Intrinsic
Value
(in thousands)
Balance—January 31, 2020
412,401 80,903,200 $6.21 8.6$1,546,313 
Shares authorized20,870,187 — 
Options granted(610,936)610,936 $26.64 
Options exercised — (4,945,720)$2.23 
Options forfeited1,354,238 (1,354,238)$5.47 
Repurchase of unvested common stock40,000 — 
RSUs granted(2,295,492)— 
RSUs forfeited10,000 — 
Balance—April 30, 2020
19,780,398 75,214,178 $6.65 8.5$2,416,057 
Options granted(130,025)130,025 $34.49 
Options exercised— (1,898,922)$5.19 
Options forfeited1,216,461 (1,216,461)$8.68 
RSUs granted(2,587,289)— 
RSUs forfeited19,550 — 
Balance—July 31, 2020
18,299,095 72,228,820 $6.70 8.2$6,227,842 
Shares authorized34,100,000
Shares ceased to be available for issuance under the 2012 Plan(15,696,031)
Options granted(136,000)136,000$71.91 
Options exercised(2,186,819)$4.74 
Options forfeited543,634(543,634)$7.52 
RSUs granted(2,841,823)
RSUs forfeited73,300
Balance—October 31, 2020
34,342,17569,634,367$6.88 8.0$16,930,996 
Vested and exercisable as of October 31, 2020
26,842,544$4.86 7.4$6,580,709 
Schedule of Unvested RSA Rollforward
Restricted Stock Awards—Restricted stock award activity during the nine months ended October 31, 2020 is as follows:
Under the PlanOut of the Plan
Number of SharesWeighted-Average Grant Date
Fair Value
per Share
Number of SharesWeighted-Average Grant Date
Fair Value
per Share
Unvested Balance—January 31, 2020
16,700 $8.58 1,603,562 $2.06 
Vested(16,700)$8.58 (27,912)$2.38 
Unvested Balance—April 30, 2020
— $— 1,575,650 $2.06 
Vested— $— (652,914)$1.99 
Unvested Balance—July 31, 2020
— $— 922,736 $2.11 
Vested— $— (90,412)$2.10 
Unvested Balance—October 31, 2020
— $— 832,324 $2.11 
Schedule of Unvested RSU Rollforward
RSU activity during the nine months ended October 31, 2020 was as follows:
Number of SharesWeighted-Average Grant Date
Fair Value
per Share
Unvested Balance—January 31, 2020
— $— 
Granted2,295,492 $38.77 
Forfeited(10,000)$38.77 
Unvested Balance—April 30, 2020
2,285,492 $38.77 
Granted2,587,289 $67.02 
Forfeited(19,550)$38.77 
Unvested Balance—July 31, 2020
4,853,231 $53.83 
Granted2,841,823 $113.53 
Vested(5,657)$45.95 
Forfeited(73,300)$75.29 
Unvested Balance—October 31, 2020
7,616,097 $75.91 
Valuation Assumptions Schedule The following table summarizes the weighted-average assumptions used in estimating the fair value of stock options granted to employees and non-employees for the three and nine months ended October 31, 2020 and 2019:
Three Months Ended October 31,Nine Months Ended October 31,
2020201920202019
Expected term (in years)5.96.16.06.0
Expected volatility38.4 %36.9 %37.2 %37.0 %
Risk-free interest rate0.4 %1.4 %1.0 %2.0 %
Expected dividend yield— %— %— %— %
Valuation Assumptions Other Than Stock Options Schedule
The following table summarizes the weighted-average assumptions used in estimating the fair value of ESPP for the initial offering period using the Black-Scholes option-pricing model:

Three and Nine Months Ended
October 31, 2020
Expected term (in years)0.5
Expected volatility60.1 %
Risk-free interest rate0.1 %
Expected dividend yield— %
Share-based Compensation Schedule
Stock-based compensation expense included in the condensed consolidated statements of operations was as follows (in thousands):
Three Months Ended October 31,Nine Months Ended October 31,
2020201920202019
Cost of revenue$13,226 $832 $15,507 $2,682 
Sales and marketing39,481 4,802 49,714 15,428 
Research and development39,368 4,411 49,186 10,822 
General and administrative27,066 12,913 43,383 28,493 
Stock-based compensation, net of amounts capitalized119,141 22,958 157,790 57,425 
Capitalized stock-based compensation284 334 1,020 786 
Total stock-based compensation$119,425 $23,292 $158,810 $58,211